Evidence map›Paper›PMID 41357176›Full record

ArticleFrontiers in immunology2025

Correction: Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Fanchao Wei, Zhaoxiang Wang, Ruochen Qi, Jingliang Zhang, Shichao Han, Changhong Shi, Tong Lu, Zhite Zhao, Zhengxuan Li, Lang Li and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Fanchao Wei *Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Zhaoxiang Wang *Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Ruochen Qi *Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Jingliang ZhangDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Shichao HanDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Changhong ShiDivision of Cancer Biology, Laboratory Animal Center, Air Force Medical University, Xi'an, Shaanxi, China.
Tong LuDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Zhite ZhaoDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Zhengxuan LiDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Lang LiSkills Training Center, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Weijun QinDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Shuaijun MaDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Lijun YangDepartment of Urology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1663251.].

Indexed as

acute rejectionCc3-Ccr5kidney transplantmacrophagesScRNA-seq

Identifiers

PMID41357176
PMCPMC12679939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.